• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

99mTc示踪剂的化学性质。II. 标记的羟乙二膦酸盐和焦磷酸盐(骨摄取剂)在体外转化为葡萄糖酸盐(肾显像剂)。钙和亚铁对体内分布的影响。

Chemistry of 99mTc tracers. II. In vitro conversion of tagged HEDP and pyrophosphate (bone-seekers) into gluconate (renal agent). Effects of Ca and Fe (ii) on in vivo distribution.

作者信息

McRae J, Hambright P, Valk P, Bearden A J

出版信息

J Nucl Med. 1976 Mar;17(3):208-11.

PMID:175138
Abstract

Sodium gluconate transforms the bone-seekers 99mTc-HEDP and 99mTc-pyrophosphate into the renal agent 99mTc-gluconate. In these in vitro processes, pyrophosphate is displaced faster than HEDP, while the HEDP reaction is accelerated by calcium ions. The in vivo distributions of these bone and kidney agents are altered by the prior local injection of calcium or iron(II). These transformation and translocation phenomena are explained in terms of the mechanistic behavior of Tc(IV) complexes.

摘要

葡萄糖酸钠可将亲骨性放射性药物99mTc - HEDP和99mTc - 焦磷酸盐转化为肾显像剂99mTc - 葡萄糖酸盐。在这些体外过程中,焦磷酸盐的取代速度比HEDP快,而钙离子可加速HEDP的反应。预先局部注射钙或亚铁会改变这些骨显像剂和肾显像剂的体内分布。这些转化和移位现象可根据Tc(IV)配合物的作用机制来解释。

相似文献

1
Chemistry of 99mTc tracers. II. In vitro conversion of tagged HEDP and pyrophosphate (bone-seekers) into gluconate (renal agent). Effects of Ca and Fe (ii) on in vivo distribution.99mTc示踪剂的化学性质。II. 标记的羟乙二膦酸盐和焦磷酸盐(骨摄取剂)在体外转化为葡萄糖酸盐(肾显像剂)。钙和亚铁对体内分布的影响。
J Nucl Med. 1976 Mar;17(3):208-11.
2
Chemistry of technetium radiopharmaceuticals. I. Exploration of the tissue distribution and oxidation state consequences of technetium (IV) in Tc-Sn-gluconate and Tc-Sn-EHDP using carrier 99Tc.锝放射性药物的化学。I. 使用载体⁹⁹Tc探索锝(IV)在葡萄糖酸锝-锡和羟基亚乙基二膦酸锝-锡中的组织分布及氧化态影响。
J Nucl Med. 1975 Jun;16(6):478-82.
3
Technetium-99m-methylene diphosphonate--a superior agent for skeletal imaging: comparison with other technetium complexes.锝-99m-亚甲基二膦酸盐——一种用于骨骼成像的优质试剂:与其他锝配合物的比较。
J Nucl Med. 1975 Aug;16(8):744-55.
4
Technetium-99m-pyrophosphate: studies in vivo and in vitro.锝-99m-焦磷酸盐:体内和体外研究
J Nucl Med. 1975 Jan;16(1):40-5.
5
Kinetics of various 99mTc-Sn-pyrophosphate compounds in the rat. II. In vitro studies.
Nuklearmedizin. 1977 Aug;16(4):157-62.
6
Kinetics of various 99mTc-Sn-pyrophosphate compounds in the rat. I. In vivo studies.
Nuklearmedizin. 1977 Jul;16(3):100-3.
7
Complexing of reduced technetium and tin (II) by chelating phosphate compounds. I. Chemical state of technetium.螯合磷酸盐化合物对还原态锝和锡(II)的络合作用。I. 锝的化学状态
Nuklearmedizin. 1979 May;18(2):98-104.
8
[Comparative evaluation of the accumulation of 99mTc-labeled phosphate compounds in the bones].[99mTc 标记的磷酸盐化合物在骨骼中蓄积的比较评估]
Eksp Onkol. 1985;7(1):66-7.
9
Complexing of reduced technetium and tin(II) by chelating phosphate compounds. II. In vitro stability of pyrophosphate and ethane-1, hydroxy-1, diphosphonate (EHDP) complexes.还原态锝与锡(II)通过螯合磷酸盐化合物形成络合物。II. 焦磷酸盐和乙烷-1-羟基-1,1-二膦酸盐(EHDP)络合物的体外稳定性。
Nuklearmedizin. 1979 May;18(2):105-9.
10
99mTc-labelled compounds prepared with sodium dithionite as reducing agent.以连二亚硫酸钠作为还原剂制备的99mTc标记化合物。
Nuklearmedizin. 1981 Dec;20(6):283-9.

引用本文的文献

1
Altered Biodistribution of Tc-DPD on Bone Scan After Intravenous Iron Supplement.静脉补铁后骨扫描中锝-二膦酸盐的生物分布改变。
Nucl Med Mol Imaging. 2017 Dec;51(4):347-349. doi: 10.1007/s13139-017-0486-5. Epub 2017 Jul 25.
2
Transient splenic uptake of 99mTc-MDP associated with haemolysis.
Eur J Nucl Med. 1982;7(11):510-2. doi: 10.1007/BF00257218.
3
Unusual extraosseous tumoral accumulation of 99mTc-MDP.99mTc-MDP异常的骨外肿瘤性聚集。
Eur J Nucl Med. 1985;10(7-8):362-5. doi: 10.1007/BF00251313.